CN109666626A - Single celled method is separated from sample - Google Patents
Single celled method is separated from sample Download PDFInfo
- Publication number
- CN109666626A CN109666626A CN201811595504.7A CN201811595504A CN109666626A CN 109666626 A CN109666626 A CN 109666626A CN 201811595504 A CN201811595504 A CN 201811595504A CN 109666626 A CN109666626 A CN 109666626A
- Authority
- CN
- China
- Prior art keywords
- sample
- digestive juice
- tissue
- method described
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to unicellular separation field, discloses and separate single celled method from sample.It is digested the described method includes: normal tissue sample is mixed with digestive juice, the digestive juice contains VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxyribonuclease, wherein, the ratio between the VIII Collagenase Type, neutral proteinase, trypsin inhibitor and the enzyme activity unit of deoxyribonuclease is 100-312.5:1-5:5000-25000:1.The present invention can realize that single celled high yield and high motility rate are extracted in the case where total digestion time is shorter, especially pancreatic tissue, capture the unicellular yield of existing pancreatic tissue and the lower problem of motility rate.
Description
Technical field
The present invention relates to unicellular separation fields, and in particular to single celled method is separated from sample.
Background technique
Pancreas is the organ that endocrine and exocrine function are had both in human body.It is thin comprising islet cells, acinus in histology
Multiple cellular components such as born of the same parents, vessel cell and interstitial cell.Pancreas generates in the pancreatic juice of secretion containing trypsase, pancreas fat
A variety of digestive ferments such as enzyme, amylopsin.With the rise of single cell analysis technology in recent years, people couple and human tissue organ
Research is mixed from heterogeneity, and the global tissue analysis interfered with each other is gradually deep into the individual cells for constituting histoorgan
Research, importance are self-evident.And in pancreas research field, due to pancreas organ's generally softness in fragile, histology
Complicated component and it is easy to happen autodigestion because of potent pancreatin, so that pancreatic single cell research often stops at first
Step --- namely the single celled acquisition of pancreatic tissue for analysis.
Human body or the unicellular separation method of animal model tissue organ are drawn from initial capillary, again to airflow classification
To micro-fluidic technologies, numerous single-cell techniques more or less all achieves more satisfied knot in different tissues
Fruit, but it is then barely satisfactory in pancreatic tissue.By consulting literatures it is found that researcher is slender in separating mouse cancer of pancreas at present
When born of the same parents, the enzymic digestion dissociating method based on II Collagenase Type is mostly used greatly, and still, pancreatic single cell researcher indicates in pancreas
Greatly challenge is encountered when the unicellular separation of gland or unicellular yield is not high or Cell viability is lower, therefore, exploitation
The preparation or method for the pancreatic single cell that can be efficiently separated have particularly important meaning.
Summary of the invention
The purpose of the invention is to overcome the problems, such as that unicellular yield and Cell viability of the existing technology are lower, mention
For separating single celled method in a kind of new slave sample.
To achieve the goals above, the present invention provides one kind separates single celled method from sample, this method comprises:
Normal tissue sample is mixed with digestive juice and is digested, the digestive juice contains VIII Collagenase Type, neutral proteinase, pancreas egg
White enzyme inhibitor and deoxyribonuclease, wherein the VIII Collagenase Type, neutral proteinase, trypsin inhibitor and
Ratio between the enzyme activity unit of deoxyribonuclease is 100-312.5:1-5:5000-25000:1.
Through the above technical solutions, the present invention can realize single celled high yield in the case where total digestion time is shorter
It is extracted with high motility rate, is based particularly on the unicellular separation of pancreatic tissue, has captured the unicellular yield of existing pancreatic tissue and work
The lower problem of rate specifies direction for the single celled separation of pancreatic tissue, may advantageously facilitate to the further of pancreatic tissue
Research.
Detailed description of the invention
Fig. 1 is to separate single celled result figure from pancreatic tissue using the method for specific embodiment according to the present invention;
Fig. 2 to Fig. 5 is to separate single celled result figure from pancreatic tissue using different reference methods respectively.
Specific embodiment
The endpoint of disclosed range and any value are not limited to the accurate range or value herein, these ranges or
Value should be understood as comprising the value close to these ranges or value.For numberical range, between the endpoint value of each range, respectively
It can be combined with each other between the endpoint value of a range and individual point value, and individually between point value and obtain one or more
New numberical range, these numberical ranges should be considered as specific open herein.
In the present invention, in the absence of explanation to the contrary, term " enzyme activity unit " reaction used is that enzyme contains
Amount number, refer under given conditions, converted in 1 minute in 1 micromole substrate or substrate needed for the related group of 1 micromole
Enzyme amount, referred to as an enzyme activity unit (IU, also known as U).
Wherein, the definition of the enzyme activity unit of VIII Collagenase Type is: under conditions of pH 7.5 and 37 DEG C, hydrolysis in 5h
It is an enzyme activity unit that collagen, which generates and is equivalent to the enzyme amount of the L-Leu of 1 μm of ol,.
The definition of the enzyme activity unit of neutral proteinase is: under conditions of pH 7.5 and 37 DEG C, hydrolyzing junket egg per minute
The white enzyme amount for generating the Folin positive amino acid or peptide that are equivalent to 1 μm of ol tyrosine is an enzyme activity unit.
The definition of the enzyme activity unit of trypsin inhibitor is: can inhibit the vigor of a trypsase enzyme activity unit
A referred to as inhibitor enzyme activity unit (U), under conditions of pH 7.5 and 25 DEG C, each second hydrolyzes the N- benzoyl-of 1 μm of ol
L-arginine ethyl ester (BAEE) is a trypsase enzyme activity unit.
The definition of the enzyme activity unit of deoxyribonuclease is: under conditions of pH 8.0 and 37 DEG C, energy in 10 minutes
Enzyme amount needed for the pBR322 Plasmid DNA of enough degradable 1 μ g is an enzyme activity unit.
It is provided by the invention that single celled method is separated from sample includes: to be mixed into normal tissue sample and digestive juice
Row digestion, the digestive juice contain VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxyribonuclease.
In the method, the ratio between VIII Collagenase Type and the enzyme activity unit of deoxyribonuclease is 100-
312.5:1, as 100:1,120:1,130:1,150:1,180:1,200:1,220:1,240:1,260:1,280:1,300:1,
Arbitrary value between 310:1,312:1,312.5:1 or above-mentioned numerical value.
In the method, the ratio between neutral proteinase and the enzyme activity unit of deoxyribonuclease is 1-5:1, such as
Arbitrary value between 1:1,1.5:1,2:1,2.5:1,3:1,3.5:1,4:1,4.5:1,5:1 or above-mentioned numerical value.
In the method, the ratio between trypsin inhibitor and the enzyme activity unit of deoxyribonuclease is
5000-25000:1, as 5000:1,8000:1,9000:1,10000:1,12000:1,15000:1,18000:1,20000:1,
Arbitrary value between 22000:1,24000:1,25000:1 or above-mentioned numerical value.
Clostridiopetidase A is that unique one kind can degrade the protease of the natural collagen fibre with three strands of superhelixes, this
Collagenous fibres are widely present in connective tissue.Clostridiopetidase A mainly by the fermented culture of clostridium histolyticum, is extracted, is refined
And obtain, it can also extract and obtain from pig pancreas.In the present invention, the clostridiopetidase A is VIII Collagenase Type, for example, can be
The Cat:C2139 of Sigma.
In the present invention, the specific type of neutral proteinase and deoxyribonuclease is not required particularly, Ke Yiwei
The common various selections in this field.
Preferably, the neutral proteinase is Dispase II.For example, the Cat:4942078001 of Roche.
Preferably, the deoxyribonuclease is DNaseI.For example, the Cat:M0303S of NEB.
In the present invention, trypsin inhibitor can inhibit trypsase and chymotrypsin, prevent the active egg of other in pancreas
The activation of white proenzyme and itself activation of trypsinogen, can choose trypsin inhibitor commonly used in the art.Example
Such as, the Cat:T6522 of Sigma.
In the present invention, the digestive juice contains solvent.Relative to every milligram of VIII Collagenase Type, the content of the solvent
Can be 0.1-12.5mL, preferably 0.2-3mL, as 0.2mL, 0.4mL, 0.5mL, 0.8mL, 1mL, 1.2mL, 1.3mL,
Arbitrary value between 1.5mL, 2mL, 2.5mL or above-mentioned numerical value.
In the present invention, the solvent can be various common preservations or the reagent of dissolution enzyme preparation, it is preferable that described molten
Agent is the phosphate buffer containing 4-10 volume % fetal calf serum.
In the present invention, the dosage of the digestive juice is not required particularly, as long as the sample can be submerged.It is excellent
It is 1cm relative to volume in the case of choosing3Normal tissue sample, the dosage of the digestive juice is 10-60mL, as 10mL,
15mL, 20mL, 25mL, 26mL, 27mL, 28mL, 30mL, 32mL, 35mL, 40mL, 45mL, 50mL, 55mL, 60mL or above-mentioned number
Arbitrary value between value.
In the present invention, in order to preferably be digested, the volume of the normal tissue sample is preferably 1-2cm × 1-2cm
× 0.5-2cm, such as 1.5cm × 1.5cm × 0.5cm.
In the present invention, the digestion can carry out under normal conditions.Preferably, the condition of the digestion includes that temperature is
It is 35-38 DEG C, such as any between 35 DEG C, 36 DEG C, 36.5 DEG C, 36.8 DEG C, 37 DEG C, 37.2 DEG C, 37.5 DEG C, 38 DEG C or above-mentioned numerical value
Value.
Preferably, the condition of the digestion further include the time be 5-80min, as 5min, 10min, 20min, 25min,
30min, 35min, 40min, 45min, 50min, 55min, 60min, 65min, 70min, 75min, 80min or above-mentioned numerical value it
Between arbitrary value.
In the present invention, it is adhered pockets of treatments of the sample in order to further speed up, it can be with shear sample and/or by suction pipe
(such as Wu Junbushi suction pipe) blows and beats sample.It filters after a period of time can also be digested through cell sieve, is mended into indigested sample
Continue to digest after adding digestive juice.That is, the mode of the digestion can be with are as follows: mix sample with first part digestive juice, shear
Sample, and the sample after shearing is mixed with second part digestive juice, sample is blown and beaten, cell sieve is crossed;Indigested sample is added
Digestive juice continues digestion repeatedly, crosses cell sieve collection respectively and adds the digestion product obtained after digestive juice every time.Relative to volume
For 1cm3Normal tissue sample, the dosage of first part's digestive juice can be 400-1000 μ L.It is 1cm relative to volume3Just
Normal tissue sample, the dosage of second part digestive juice can be 5-20mL.It is 1cm relative to volume3Normal tissue sample, often
The dosage of the secondary digestive juice added can be 5-20mL.
In the present invention, in order to further promote the progress of digestion, the method also includes: before digestion, in tissue preserration
Fiber, fat and the necrotic tissue of normal tissue sample are removed in liquid.
Wherein, the dosage of the tissue preserration liquid is not required particularly, as long as the sample can be submerged.Institute
Stating tissue preserration liquid can be conventional selection, for example, can be the serum-free cell containing fetal calf serum and protease inhibitors
Freezing media.
In the present invention, the method also includes: postdigestive sample is contacted with erythrocyte cracked liquid to crack red thin
Born of the same parents obtain the unicellular of separation after washing.Postdigestive sample be cell suspending liquid, be centrifuged and take precipitating, precipitate with it is red
Cell pyrolysis liquid is contacted to remove red blood cell.The dosage of the erythrocyte cracked liquid can be conventional selection, for example, relative to body
Product is 1cm3Normal tissue sample, the dosage of the erythrocyte cracked liquid can be 3-8ml.Washing lotion used in washing can also
Conventional selection is thought, for example, can be the phosphate buffer containing 0.02-0.08 weight % bovine serum albumin.It is washed to described
The dosage of liquid is not particularly limited, for example, being 1cm relative to volume3Normal tissue sample, the dosage of the washing lotion can be with
For 3-8ml.
A kind of specific embodiment according to the present invention, the described method comprises the following steps:
1) in tissue preserration liquid, the fiber cut on normal tissue sample, fat and downright bad group are pruned with Sterile ophthalmic
It knits;
2) sterile PBS washing;
3) sample is put into sterile centrifugation tube, it (is 1cm relative to volume that first part's digestive juice, which is added,3Normal group
Tissue samples, the dosage of first part's digestive juice can be 400-1000 μ L);
4) it is cut using Sterile ophthalmic and tissue is cut into clast (about 2 × 2 × 1mm3), it operates on ice, shear time is no more than 5
Minute;
5) tissue debris is transferred in sterile petri dish, it (is 1cm relative to volume that second part digestive juice, which is added,3's
Normal tissue sample, the dosage of second part digestive juice can be 5-20mL);
6) it is blown and beaten using Wu Junbushi suction pipe, collects supernatant and cross cell sieve, take filtrate, indigested tissue debris, which is added, to disappear
Change liquid continue to digest in sterile petri dish, until tissue digestion completely or obtain satisfied normal tissue it is unicellular (relative to
Volume is 1cm3Normal tissue sample, the dosage for the digestive juice added every time can be 5-20mL);
7) filtrate obtained in step 6) is centrifuged;
8) abandon supernatant, be added lysate softly blow and beat, be resuspended precipitating, be protected from light at room temperature split it is red, if there is cotton-shaped indissoluble object,
Cell is crossed again weed out remove;
9) re-suspension liquid is transferred in sterile centrifugation tube and is centrifuged;
10) supernatant is abandoned, first part's washing lotion is added and softly blows and beats resuspension precipitating, it is meticulous again if there is cotton-shaped indissoluble object
Born of the same parents, which weed out, to be removed, and re-suspension liquid is transferred to new sterile centrifugation tube and continuously adds second part washing lotion (first part's washing lotion and the
The volume ratio of two part washing lotions can be 1:4-5);
11) it is centrifuged;
12) step 10) is repeated;
13) it is centrifuged.
In the present invention, the method can also include using cell culture medium to digesting resulting unicellular cultivate.
The cell culture medium can be the conventional medium for expanding cell, or the dimensional culture base containing growth factor,
So that the single cells grown obtained is three-dimensional organoid model.
In the present invention, the normal tissue sample can be common tissue sample, can be pancreatic samples, such as tumour
The normal pancreatic tissue at place position.It is unicellular method of the invention is particularly suitable for being separated from pancreatic samples, therefore, according to
The preferred embodiment of the present invention, the normal tissue sample are the normal pancreatic tissue at position where tumour.
The present invention will be described in detail by way of examples below.
Table 1
Table 2
Embodiment 1
The present embodiment is used to illustrate of the invention single from normal pancreatic tissue (Normal Pancreas at position where tumour) separation
The method of cell, wherein used tissue preserration liquid, digestive juice, lysate and washing lotion are as shown in table 1, in every liter of digestive juice
The enzyme activity unit value and concentration of each ingredient are as shown in table 2, and the preparation method of digestive juice are as follows: mixing VIII Collagenase Type,
Dispase II and trypsin inhibitor dissolve mixing powder using solvent, add DNaseI mixing.
Sample is divided into five groups and is tested and (be shown in Table 3), specific steps are as follows:
1) in tissue preserration liquid, it is (normal that fiber, fat and necrotic tissue cut on sample etc. is pruned with Sterile ophthalmic
Pancreatic tissue block size about 1.5 × 1.5 × 0.5cm3, color is yellow, and quality is medium partially soft, and surface is cut without black burnt necrosis, too many blood
The visible clearly pancreas leaflet in face separates, and derives from pancreatic neoplasm patient, and operation cuts acquisition, patient's signed informed consent
Book).
2) sterile PBS is washed 3 times.
3) sample is put into 5ml sterile EP tube (eppendorf), about 500 μ l of digestive juice is added.
4) it is cut using Sterile ophthalmic and tissue is cut into clast (about 2 × 2 × 1mm3), it operates on ice, shear time is no more than 5
Minute.
5) tissue debris is transferred in 10cm sterile petri dish, 10ml digestive juice is added, be placed in 37 DEG C of incubator digestion.
6) it is mixed once every 5min using the piping and druming of Wu Junbushi suction pipe, and is seen under 10 × 20,10 × 40 power microscopes
Examine cell dissociation situation.There is individual cells suspension in visible digestive juice under the microscope when first 10min, by digestive juice
It is collected into sterile 50ml centrifuge tube together with tissue debris, is stood after soft piping and druming, collect supernatant and cross 40 μm of cell sieve (cell
Strainer), filtrate is taken.Indigested tissue debris adds digestive juice 10ml and continues to digest in 10cm sterile petri dish, directly
It completely or obtains that satisfied pancreas normal tissue is unicellular (altogether continue 50min) to tissue digestion, first 10min is collected
Filtrate is given it up, and because it contains more impurity, separates unicellular difficulty.The filtrate that later every 10min digests can be distinguished
It retains, carries out aftermentioned operating procedure respectively, finally choose motility rate, the optimal single cell suspension sample of cell quantity.
7) filtrate 800g obtained in step 6) is centrifuged 4min (using horizontal rotor).
8) supernatant is abandoned, 5ml lysate is added and softly blows and beats, precipitating is resuspended, is protected from light splits red 5min (if there is cotton-shaped difficulty at room temperature
Molten object then crosses 40 μm of cell sieve removals again).
9) re-suspension liquid is transferred in sterile 15ml centrifuge tube and is centrifuged, centrifugal force: 800g, time: 4min.
10) supernatant is abandoned, addition 1ml washing lotion softly blows and beats resuspension precipitating and (if there is cotton-shaped indissoluble object, crosses 40 μm of cells again
Weed out and remove), re-suspension liquid is transferred to a new sterile 15ml centrifuge tube and continuously adds 5ml washing lotion.
11) 600g is centrifuged 5min.
12) step 10) is repeated.
13) 400g is centrifuged 6min.
14) supernatant is abandoned, precipitating is resuspended in appropriate washing lotion, and (precipitating of covering 15ml centrifugation bottom of the tube, uses 100 μ l washing lotion weights
It is outstanding), take isometric cell and trypan blue to mix, microscopy cellular morphology, motility rate, impurity situation etc., cell counter (life
Cell countess) detection Cell viability (living cells quantity accounts for the percentage of total number of cells in=every ml product) is (every with concentration
Total number of cells in ml product, including dead cell), as a result as shown in Fig. 1-5 and table 3.
In Fig. 1-5, upper figure is the result figure for observing digestion effect after digesting under ordinary optical microscope (40 ×), the following figure
For the result figure for observing Cell viability after further diluting under ordinary optical microscope (40 ×).
Table 3
From Fig. 1 and table 3 as can be seen that can effectively be separated from normal tissue using method of the invention it is unicellular,
Basic soilless sticking, Cell viability is 85% or more.
From Fig. 2, Fig. 3 and table 3 as can be seen that if the ratio in digestive juice between each component is not in the scope of the present invention
Interior, cell, which exists, after digestion reunites, and Cell viability is relatively low.
From Fig. 4 and table 3 as can be seen that can be obtained using VIII Collagenase Type more significantly more than other types of clostridiopetidase A
Unicellular and Cell viability it is also higher.
From Fig. 5 and table 3 as can be seen that being only used cooperatively VIII Collagenase Type, neutral proteinase, trypsin inhibitor
Single cells population (reuniting few) and Cell viability can be effectively improved with deoxyribonuclease, four kinds of ingredients are indispensable,
Collaboration plays a role.
Embodiment 2
The present embodiment is used to illustrate of the invention from the single celled method of pancreas source tumor tissues separation, wherein is made
Tissue preserration liquid, digestive juice, lysate and washing lotion are as shown in table 1, each in every liter of digestive juice (preparation method is with embodiment 1)
The enzyme activity unit value and concentration of a ingredient are as shown in the I-1 of table 2.
1) it in tissue preserration liquid, is pruned with Sterile ophthalmic and cuts pancreatic neoplasm sample (1.5 × 1.5 × 0.5cm3, operation
Cut acquisition, patient's signed informed consent form) on fiber, fat and necrotic tissue etc..
2) sterile PBS is washed 3 times.
3) sample is put into 5mL sterile EP tube (eppendorf), about 500 μ l of digestive juice is added.
4) it is cut using Sterile ophthalmic and tissue is cut into clast (about 2 × 2 × 1mm3), it operates on ice, shear time is no more than 5
Minute.
5) tissue debris is transferred in 50ml sterile tube, 15ml digestive juice is added, be placed in 37 DEG C, 50rmp/min shakes
It is digested on bed.
6) pockets of tissue debris piping and druming will be adhered using Wu Junbushi suction pipe after 5min to mix.
7) continue to observe tissue clastic state after digesting 5min, if being still adhered agglomerating, repeatedly step 6) -7), if tissue
Clast dispersion then continues to digest 20min, and total digestion time is no more than 30min.
8) digestion finishes, and stands 3min after reusing Wu Junbushi suction pipe piping and druming tissue debris, collects supernatant and cross 40 μm
Cell sieve (cell strainer), obtains filtrate and is placed on ice.
9) indigested tissue adds 15ml digestive juice, continues after digesting 20min, blows and beats tissue using Wu Junbushi suction pipe
Clast crosses 40 μm of cell sieves together with digestive juice and tissue debris, obtains filtrate.
10) merge the filtrate obtained twice, 800g is centrifuged 4min (using horizontal rotor).
11) supernatant is abandoned, 5ml lysate is added and softly blows and beats, precipitating is resuspended, is protected from light splits red 5min (if having cotton-shaped at room temperature
Indissoluble object then crosses 40 μm of cell sieve removals again).
12) re-suspension liquid is transferred in sterile 15ml centrifuge tube and is centrifuged, centrifugal force: 800g, time: 4min.
13) supernatant is abandoned, addition 1ml washing lotion softly blows and beats resuspension precipitating and (if there is cotton-shaped indissoluble object, crosses 40 μm of cells again
Weed out and remove), re-suspension liquid is transferred to a new sterile 15ml centrifuge tube and continuously adds 5ml washing lotion.
14) 600g is centrifuged 5min.
15) step 13) is repeated.
16) 400g is centrifuged 6min.
17) supernatant is abandoned, precipitating is resuspended in appropriate washing lotion, and (precipitating of covering 15ml centrifugation bottom of the tube, uses 100 μ l washing lotion weights
It is outstanding), take isometric cell and trypan blue to mix, microscopy cellular morphology, motility rate, impurity situation etc., cell counter (life
Cell countess) Cell viability and concentration are detected, it is as a result similar to Example 1, it can be effectively using method of the invention
Separated from tumor tissues unicellular, basic soilless sticking, Cell viability is 80% or more;And if ratio between each component
Not within the scope of the invention, after digestion there is reunion in cell, and Cell viability is relatively low;And it can be obtained using VIII Collagenase Type
It is also higher to obtain the unicellular and Cell viability more significantly more than other types of clostridiopetidase A.In addition, in the feelings for lacking a kind of ingredient
Under condition, single cells population and Cell viability are undesirable, further illustrate that four kinds of ingredients are indispensable, collaboration plays a role.
The preferred embodiment of the present invention has been described above in detail, and still, the present invention is not limited thereto.In skill of the invention
In art conception range, can with various simple variants of the technical solution of the present invention are made, including each technical characteristic with it is any its
Its suitable method is combined, and it should also be regarded as the disclosure of the present invention for these simple variants and combination, is belonged to
Protection scope of the present invention.
Claims (10)
1. one kind separates single celled method from sample, which is characterized in that this method comprises: by normal tissue sample and digestion
Liquid mixing is digested, and the digestive juice contains VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxyribose
Nuclease, wherein the enzyme activity of the VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxyribonuclease
Ratio between unit of force is 100-312.5:1-5:5000-25000:1.
2. according to the method described in claim 1, wherein, the neutral proteinase is Dispase II;
And/or the deoxyribonuclease is DNaseI.
3. method according to claim 1 or 2, wherein relative to every milligram of VIII Collagenase Type, in the digestive juice
The content of solvent is 0.1-12.5mL.
4. according to the method described in claim 3, wherein, the solvent is slow for the phosphate containing 4-10 volume % fetal calf serum
Fliud flushing.
5. according to the method described in claim 1, being 1cm relative to volume wherein3Normal tissue sample, the digestive juice
Dosage is 10-60mL.
6. method according to claim 1 or 5, wherein the volume of the normal tissue sample be 1-2cm × 1-2cm ×
0.5-2cm。
7. according to the method described in claim 1, wherein, the condition of the digestion includes: that temperature is 35-38 DEG C, time 5-
80min。
8. according to the method described in claim 1, wherein, the method also includes: before digestion, removed in tissue preserration liquid
Fiber, fat and the necrotic tissue of normal tissue sample.
9. according to the method described in claim 8, wherein, the tissue preserration liquid is to contain fetal calf serum and protease inhibitors
Serum-free cell freezing media.
10. according to claim 1, method described in 8 or 9, wherein the method also includes: by postdigestive sample and red thin
The contact of cellular lysate liquid obtains the unicellular of separation to splitting erythrocyte after washing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811595504.7A CN109666626A (en) | 2018-12-25 | 2018-12-25 | Single celled method is separated from sample |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811595504.7A CN109666626A (en) | 2018-12-25 | 2018-12-25 | Single celled method is separated from sample |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109666626A true CN109666626A (en) | 2019-04-23 |
Family
ID=66146204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811595504.7A Pending CN109666626A (en) | 2018-12-25 | 2018-12-25 | Single celled method is separated from sample |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109666626A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113122492A (en) * | 2021-03-15 | 2021-07-16 | 中国人民解放军海军军医大学 | Single cell separation method for hydranth of sea moon medusa |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100150876A1 (en) * | 2006-11-24 | 2010-06-17 | Regents Of The Univeristy Of Minnesota | Endodermal progenitor cells |
CN108103013A (en) * | 2018-01-26 | 2018-06-01 | 河北医科大学第四医院 | The enzyme digestion original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell |
CN108373994A (en) * | 2018-01-26 | 2018-08-07 | 河北医科大学第四医院 | The tissue block method's original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell |
-
2018
- 2018-12-25 CN CN201811595504.7A patent/CN109666626A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100150876A1 (en) * | 2006-11-24 | 2010-06-17 | Regents Of The Univeristy Of Minnesota | Endodermal progenitor cells |
CN108103013A (en) * | 2018-01-26 | 2018-06-01 | 河北医科大学第四医院 | The enzyme digestion original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell |
CN108373994A (en) * | 2018-01-26 | 2018-08-07 | 河北医科大学第四医院 | The tissue block method's original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell |
Non-Patent Citations (7)
Title |
---|
侯晶岩: "《医学细胞生物学实验指导及习题集》", 31 August 2018, 汕头大学出版社 * |
刘斌 等: "《细胞培养》", 31 January 2018, 世界图书出版公司 * |
吴燕峰 等: "《实用医学细胞培养技术》", 31 January 2010, 中山大学出版社 * |
李杨 等: "联合应用乌斯他丁和DNA酶提高分离胰岛的效果的实验研究", 《2012中国器官移植大会论文汇编》 * |
苏泽轩 等: "《现代移植学》", 31 December 1998, 人民卫生出版社 * |
袁世珍: "《胰腺癌》", 31 December 2001, 上海科学技术出版社 * |
袁耀宗 等: "《消化系疾病临床新技术》", 28 February 2002, 人民军医出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113122492A (en) * | 2021-03-15 | 2021-07-16 | 中国人民解放军海军军医大学 | Single cell separation method for hydranth of sea moon medusa |
CN113122492B (en) * | 2021-03-15 | 2022-12-02 | 中国人民解放军海军军医大学 | Single cell separation method for hydranth of sea moon medusa |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109666625A (en) | Single celled method is separated from tissue | |
CN109666644A (en) | Single celled method is separated from tumor sample | |
CN112708610B (en) | Mixed enzyme for skin tissue dissociation, preparation method thereof, dissociation kit and dissociation method | |
CN109694845A (en) | For separating single celled kit and its application | |
CA2948952C (en) | Process and device for isolating cells from biological tissue | |
EP1266959A2 (en) | Devices and method for cell harvesting | |
CN109609439A (en) | Single celled method is separated from non-normal tissue | |
JPH02504222A (en) | Methods for isolating subtype cell clusters from organs | |
CN112662614B (en) | Kit and method for preparing pancreatitis tissue single-cell suspension | |
US20150231244A1 (en) | Regenerative cell and adipose-derived stem cell processing system and method | |
CN115322964B (en) | Construction method of 3D culture amniotic mesenchymal stem cell seed bank | |
CN109628434A (en) | It is single celled containing enzymatic compositions and its preparation method and application for separating | |
CN109666626A (en) | Single celled method is separated from sample | |
CN109609438A (en) | Single celled method is separated from non-tumor sample | |
CN109536449A (en) | Single celled method is separated from abnormal structure | |
CN115851587A (en) | Optimized culture medium, kit and culture method of human placenta-derived mesenchymal stem cells | |
CN109694846A (en) | Kit and its application containing trypsin inhibitor | |
CN112175902B (en) | Separation method of adipose-derived stem cells | |
CN109735515A (en) | Composition and its preparation method and application containing clostridiopetidase A | |
CN107227295A (en) | Come off separation and the in-vitro multiplication method of deciduous teeth stem cell | |
CN109666624A (en) | Kit and its application containing clostridiopetidase A | |
CN116590235B (en) | Efficient digestive tract tumor organoid culture method | |
ES2784253T3 (en) | Procedure for the production of an enzymatic cocktail from mushroom must | |
CN109762796A (en) | Composition and its preparation method and application containing trypsin inhibitor | |
CN106676063A (en) | Separate culture method for human amniotic mesenchymal stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190423 |
|
RJ01 | Rejection of invention patent application after publication |